Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms

L Rochette, C Guenancia, A Gudjoncik… - Trends in …, 2015 - cell.com
Anticancer drugs continue to cause significant reductions in left ventricular ejection fraction
resulting in congestive heart failure. The best-known cardiotoxic agents are anthracyclines …

Survivin, a cancer target with an emerging role in normal adult tissues

S Fukuda, LM Pelus - Molecular cancer therapeutics, 2006 - AACR
Survivin, an inhibitor of apoptosis protein, is highly expressed in most cancers and
associated with chemotherapy resistance, increased tumor recurrence, and shorter patient …

MnO 2 nanosheets as a carrier and accelerator for improved live-cell biosensing application of CRISPR/Cas12a

DX Wang, YX Wang, J Wang, JY Ma, B Liu… - Chemical …, 2022 - pubs.rsc.org
Besides gene-editing, the CRISPR/Cas12a system has also been widely used in in vitro
biosensing, but its applications in live-cell biosensing are rare. One reason is lacking …

The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer

B Nachmias, Y Ashhab, D Ben-Yehuda - Seminars in cancer biology, 2004 - Elsevier
Apoptosis is a crucial biological process that prevents uncontrolled cell proliferation and
eliminates harmful cells. Resistance to apoptotic stimuli is a hallmark feature of various …

Nuclear or cytoplasmic expression of survivin: what is the significance?

F Li, J Yang, N Ramnath, MM Javle… - International journal of …, 2005 - Wiley Online Library
Growing evidence suggests that survivin expression in cancer cell nuclei may represent an
important prognostic marker to predict disease outcome for cancer patients. Current reports …

Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma

Z Khan, AA Khan, H Yadav, GBKS Prasad… - Cellular & molecular …, 2017 - Springer
Squamous cell carcinoma (SCC) is the most common cancer worldwide. The treatment of
locally advanced disease generally requires various combinations of radiotherapy, surgery …

Plasma membrane proteomics and its application in clinical cancer biomarker discovery

R Leth-Larsen, RR Lund, HJ Ditzel - Molecular & Cellular Proteomics, 2010 - ASBMB
Plasma membrane proteins that are exposed on the cell surface have important biological
functions, such as signaling into and out of the cells, ion transport, and cell-cell and cell …

Drug resistance in lung cancer

M Shanker, D Willcutts, JA Roth… - Lung Cancer: Targets …, 2010 - Taylor & Francis
Resistance to chemotherapy drugs is a major problem in cancer treatment. Scientific
advances made in the last two decades have resulted in the identification of genes and …

[HTML][HTML] Prostaglandin E2 induces fibroblast apoptosis by modulating multiple survival pathways

SK Huang, ES White, SH Wettlaufer, H Grifka… - The FASEB …, 2009 - ncbi.nlm.nih.gov
Although the lipid mediator prostaglandin E 2 (PGE 2) exerts antifibrotic effects by inhibiting
multiple fibroblast functions, its ability to regulate fibroblast survival is unknown. Here, we …

Digitoxin and its analogs as novel cancer therapeutics

HA Elbaz, TA Stueckle, W Tse, Y Rojanasakul… - … hematology & oncology, 2012 - Springer
A growing body of evidence indicates that digitoxin cardiac glycoside is a promising
anticancer agent when used at therapeutic concentrations. Digitoxin has a prolonged half …